**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

 

**FORM 10-QSB**

 

**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE            SECURITIES EXCHANGE ACT OF 1934**

For            the quarterly period ended September 30, 2007

 

Commission File Number 033-19411-C

 

 

| **TETRIDYNSOLUTIONS,INC.**                                                                                    |
|---------------------------------------------------------------------------------------------------------------|
| (Exact name of small business issuer as specified in its                            charter)                  |
|                                                                                                          |
| **Nevada**                                                                                                    | **20-5081381** |
| (State or other jurisdiction of incorporation or                            organization)                     | (I.R.S. Employer Identification No.) |
|                                                                                                          |
| **1651 Alvin Ricken Drive, Pocatello, ID                            83201**                                   |
| (Address of principal executive offices)                                                                      |
|                                                                                                          |
| **(208) 232-4200**                                                                                            |
| (Issuer’s telephone number)                                                                             |
|                                                                                                          |
| **n/a**                                                                                                       |
| (Former name, former address and former fiscal year, if                            changed since last report) |

 

 

Check whether the issuer (1) filed all reports required to be filed by            Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter            period that the registrant was required to file such reports), and (2) has been subject            to such filing requirements for the past 90 days. YESxNOo

 

Indicate by check mark whether the registrant is a shell company (as            defined in Rule 12b-2 of the Exchange Act). NOxYESo

 

State the number of shares outstanding of each of the issuer’s            classes of common equity, as of the latest practicable date:**As of November 12, 2007, issuer had 21,011,863 outstanding shares of            common stock, par value $0.001.**

 

Transitional Small Business Disclosure Format (check one):YESoNOx

 

----

**TABLE OF CONTENTS**

 

 

|                                     | **Page**                                                                                           |
|------------------------------------------|----------------------------------------------------------------------------------------------------|
|                                     |                                                                                               |
| **PART I – FINANCIAL INFORMATION** |                                                                                               |
|                                     | Item 1. Financial Statements.                                                                      | 3 |
|                                     | Condensed Consolidated Balance Sheets                            (Unaudited)                       | 3 |
|                                     | Condensed Consolidated Statements of Operations                            (Unaudited)             | 4 |
|                                     | Condensed Consolidated Statements of Cash Flows                            (Unaudited)             | 5 |
|                                     | Notes to Condensed Consolidated Financial Statements                            (Unaudited)        | 6 |
|                                     | Item 2. Management’s Discussion and Analysis or                            Plan of Operation | 12 |
|                                     | Item 3. Controls and Procedures                                                                    | 17 |
|                                     |                                                                                               |   |
| **PART II – OTHER INFORMATION**    |                                                                                               |
|                                     | Item 6. Exhibits                                                                                   | 18 |
|                                     | Signature                                                                                          | 18 |

 

             

2

 

----

**PART I – FINANCIAL INFORMATION**

 

**ITEM 1. FINANCIAL STATEMENTS**

 

| **TETRIDYN SOLUTIONS, INC. AND                            SUBSIDIARY**                                |
|-------------------------------------------------------------------------------------------------------|
| **CONDENSED CONSOLIDATED BALANCE SHEETS**                                                             |
|                                                                                                  |
|                                                                                                  |   | **September 30,** |   | **December 31,** |
|                                                                                                  |   | **2007** |   | **2006** |
|                                                                                                  |   | **(Unaudited)** |   |   |
| **ASSETS**                                                                                            |   |   |   |   |
| **Current Assets**                                                                                    |   |   |   |   |
| Cash                                                                                                  |   | $        85,065  |   | $         81,723  |
| Accounts receivable                                                                                   |   | 11,869  |   | 200  |
| **Total Current Assets**                                                                              |   | 96,934  |   | 81,923  |
| **Property and Equipment, net**                                                                       | 13,806  |   | 14,351  |
| **Total Assets**                                                                                      |   | $      110,740  |   | $         96,274  |
|                                                                                                  |   |   |   |   |
| **LIABILITIES**                                                                                       |   |   |   |   |
| **Current Liabilities**                                                                               |   |   |   |   |
| Accounts payable                                                                                      |   | $         94,296  |   | $       154,674  |
| Accrued liabilities                                                                                   |   | 88,044  |   | 79,769  |
| Deferred revenue                                                                                      |   | 62,210  |   | 57,796  |
| Notes payable, current portion                                                                        | 337,396  |   | 219,271  |
| **Total Current Liabilities**                                                                         |   | 581,946  |   | 511,510  |
| **Long-Term Liabilities**                                                                             |   |   |   |   |
| Notes payable, net of current portion                                                                 | 168,320  |   | 334,864  |
| Notes payable to related parties, net of current                            portion                   | -  |   | 77,751  |
| **Total Long-Term Liabilities**                                                                       |   | 168,320  |   | 412,615  |
| **Total Liabilities**                                                                                 |   | 750,266  |   | 924,125  |
|                                                                                                  |   |   |   |   |
| **NON-CONTROLLING INTEREST**                                                                          | 25,226  |   | -  |
|                                                                                                  |   |   |   |   |
| **STOCKHOLDERS' DEFICIT**                                                                             |   |   |   |   |
| Preferred stock - $0.001 par value                                                                    |   |   |   |
| Authorized:                                                                                           | 5,000,000 shares |   |   |   |
| Issued:                                                                                               | no shares | -  |   | -  |
| Common stock - $0.001 par value                                                                       |   |   |   |
| Authorized:                                                                                           | 100,000,000 shares |   |   |   |
| Issued and outstanding:                                                                               | 21,011,863 shares and |   |   |   |
|                                                                                                  | 20,009,350 shares, respectively | 21,012  |   | 20,009  |
| Additional paid-in capital                                                                            |   | 2,567,302  |   | 2,124,430  |
| Deferred stock compensation                                                                           |   | (91,923) |   | -  |
| Accumulated deficit                                                                                   |   | (3,161,143) |   | (2,972,290) |
| **Total Stockholders' Deficit**                                                                       |   | (664,752) |   | (827,851) |
| **Total Liabilities and Stockholders'                            Deficit**                            | $       110,740  |   | $         96,274  |
| See the accompanying notes to condensed consolidated                            financial statements. |
|                                                                                                       |  |  |  |  |  |

 

3

 

----

| **TETRIDYN SOLUTIONS, INC. AND                            SUBSIDIARY**                                |
|-------------------------------------------------------------------------------------------------------|
| **CONDENSED CONSOLIDATED STATEMENTS OF                            OPERATIONS**                        |
| **(Unaudited)**                                                                                       |
|                                                                                                  |   |   |   |   |   |   |   |
|                                                                                                  | **For the Three Months Ended** |   | **For the Nine Months Ended** |
|                                                                                                  | **September 30,** |   | **September 30,** |
|                                                                                                  | **2007** |   | **2006** |   | **2007** |   | **2006** |
|                                                                                                  |   |   |   |   |   |   | **(Restated)** |
| **Revenue**                                                                                           | $     287,193  |   | $     269,503  |   | $     846,241  |   | $     541,324  |
| **Cost of Revenue**                                                                                   | 108,637  |   | 88,011  |   | 302,495  |   | 195,020  |
| **Gross Profit**                                                                                      | 178,556  |   | 181,492  |   | 543,746  |   | 346,304  |
| **Operating Expenses**                                                                                |   |   |   |   |   |   |   |
| General and administrative                                                                            | 53,877  |   | 46,689  |   | 180,624  |   | 148,948  |
| Professional fees                                                                                     | 113,512  |   | 83,871  |   | 298,997  |   | 562,476  |
| Selling and marketing                                                                                 | 76,363  |   | 77,265  |   | 199,230  |   | 198,301  |
| Research and development                                                                              | 109,270  |   | 31,182  |   | 155,214  |   | 120,660  |
| **Total Operating Expenses**                                                                          | 353,022  |   | 239,007  |   | 834,065  |   | 1,030,385  |
| **Net Loss from Operations**                                                                          | (174,466) |   | (57,515) |   | (290,319) |   | (684,081) |
| **Other Income (Expenses)**                                                                           |   |   |   |   |   |   |   |
| Other Income (Expense)                                                                                | -  |   | -  |   | (141) |   | 37,500  |
| Non-Controlling Interest in Investee's                                                                |   |   |   |   |   |   |   |
| Net (Income)/Loss                                                                                     | 143,674  |   | -  |   | 143,674  |   | -  |
| Interest Income                                                                                       | 76  |   | 96  |   | 210  |   | 454  |
| Interest Expense                                                                                      | (12,047) |   | (15,493) |   | (42,277) |   | (57,450) |
| **Total Other Income (Expenses)**                                                                     | 131,703  |   | (15,397) |   | 101,466  |   | (19,496) |
| **Net Profit (Loss) before Provision for**  **Income                            Taxes**     | (42,763) |   | (72,912) |   | (188,853) |   | (703,577) |
| **Provision for Income Taxes**                                                                        | -  |   |   |   | -  |   |   |
| **Net Profit (Loss)**                                                                                 | $     (42,763) |   | $     (72,912) |   | $   (188,853) |   | $   (703,577) |
|                                                                                                  |   |   |   |   |   |   |   |
| **Basic and Diluted Loss Per Common                            Share**                                | $         (0.00) |   | $         (0.00) |   | $         (0.01) |   | $         (0.04) |
|                                                                                                  |   |   |   |   |   |   |   |
| **Basic and Diluted Weighted-Average**                                                                |   |   |   |   |   |   |   |
| **Common Shares Outstanding**                                                                         | 21,007,992  |   | 20,009,350  |   | 20,741,439  |   | 18,893,775  |
|                                                                                                  |   |   |   |   |   |   |   |
| See the accompanying notes to condensed consolidated                            financial statements. |
|                                                                                                  |   |   |   |   |   |   |   |

 

 

 

4

 

----

 

| **TETRIDYN SOLUTIONS, INC. AND                            SUBSIDIARY**                                               |                                                                                                                                        |
|----------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------|
| **CONDENSED CONSOLIDATED STATEMENTS OF CASH                            FLOWS**                                       |                                                                                                                                        |
| **(Unaudited)**                                                                                                      |                                                                                                                                        |
|                                                                                                                 |                                                                                                                                   |   |   |  |
|                                                                                                                 | **For the Nine Months Ended**                                                                                                          |  |
|                                                                                                                 | **September 30,**                                                                                                                      |  |
|                                                                                                                 | **2007**                                                                                                                               |   | **2006** |  |
|                                                                                                                 |                                                                                                                                   |   | **(Restated)** |  |
| **Cash Flows from Operating Activities**                                                                             |                                                                                                                                   |   |   |  |
| Net Loss                                                                                                             | $       (188,853)                                                                                   |   | $       (703,577) |  |
| Adjustments to reconcile net loss to net cash provided                            by (used in) operating activities: |                                                                                                                                   |   |   |  |
| Depreciation                                                                                                         | 9,449                                                                                                                             |   | 27,424  |  |
| Loss on disposal of asset                                                                                            | 141                                                                                                                               |   | -  |  |
| Interest expense from accretion redeemable                            stock                                          | -                                                                                                                                 |   | 12,164  |  |
| Common stock issued for services                                                                                     | 233,977                                                                                                                           |   | 443,675  |  |
| Granted stock options                                                                                                | 32,905                                                                                                                            |   | -  |  |
| Non-Controlling Interest in Investee                                                                                 | 25,226                                                                                                                            |   | -  |  |
| Changes in operating assets and liabilities:                                                                         |                                                                                                                                   |   |   |  |
| Accounts receivable                                                                                                  | (11,669)                                                                                                                               |   | 2,219  |  |
| Accured expenses                                                                                                     | 14,604                                                                                                                            |   | (11,871) |  |
| Accounts payable                                                                                                     | (60,378)                                                                                                                               |   | 93,591  |  |
| Deferred revenue                                                                                                     | 4,414                                                                                                                             |   | 1,924  |  |
| **Net Cash Provided by (Used in) Operating                            Activities**                                   | 59,816                                                                                                                            |   | (134,451) |  |
| **Cash Flows from Investing Activities**                                                                             |                                                                                                                                   |   |   |  |
| Proceeds from sale of property and equipment                                                                         | 236                                                                                                                               |   | -  |  |
| Purchase of property and equipment                                                                                   | (9,281)                                                                                                                                |   | (6,588) |  |
| **Net Cash Used in Investing Activities**                                                                            | (9,045)                                                                                                                                |   | (6,588) |  |
| **Cash Flows from Financing Activities**                                                                             |                                                                                                                                   |   |   |  |
| Principal payments on notes payable                                                                                  | (48,419)                                                                                                                               |   | (25,148) |  |
| Principal payments on notes payable to related                            parties                                    | -                                                                                                                                 |   | (15,250) |  |
| Principal payments on capital lease                            obligations                                           | -                                                                                                                                 |   | (17,635) |  |
| Proceeds from issuance of common stock                                                                               | 450                                                                                                                               |   | 161,500  |  |
| Proceeds from exercised stock options                                                                                | 540                                                                                                                               |   | 660  |  |
| **Net Cash Provided by (Used in) Financing                            Activities**                                   | (47,429)                                                                                                                               |   | 104,127  |  |
| **Net Increase (Decrease) in Cash**                                                                                  | 3,342                                                                                                                             |   | (36,912) |  |
| **Cash at Beginning of Period**                                                                                      | 81,723                                                                                                                            |   | 108,311  |  |
| **Cash at End of Period**                                                                                            | $           85,065                                                         |   | $             71,399  |  |
|                                                                                                                 |                                                                                                                                   |   |   |  |
| **Supplemental Disclosure of Cash Flow                            Information:**                                     |                                                                                                                                   |   |   |  |
| Cash paid for income taxes                                                                                           | $                     -  |   | $                       -  |  |
| Cash paid for interest expense                                                                                       | $           38,879                                                         |   |                              $           43,882  |  |
|                                                                                                                 |                                                                                                                                   |   |   |  |
|                                                                                                                 |                                                                                                                                   |   |   |  |
| **Schedule of Noncash Investing and Financing                            Activities:**                               |                                                                                                                                   |   |   |  |
| Conversion of note payable into common stock                                                                         | 84,080                                                                                                                            |   | 252,356  |  |
| Conversion of redeemable stock into common                            stock                                          | -                                                                                                                                 |   | 708,274  |  |
| Common stock issued in exchange for Creative Vending                            Corp. liabilities                    | -                                                                                                                                 |   | 4,500  |  |
| See the accompanying notes to condensed consolidated                            financial statements.                |                                                                                                                                        |
|                                                                                                                      |

 

5

----

**TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY**

**Notes to the Condensed Consolidated Financial            Statements**

(Unaudited)

 

**Note 1 – Basis of Presentation**

 

The            accompanying unaudited consolidated financial statements have been prepared in            accordance with accounting principles generally accepted in the United States of            America and the rules and regulations of the Securities and Exchange Commission for            interim financial information. Accordingly, they do not include all the information            necessary for a comprehensive presentation of financial position and results of            operations.

 

It            is management’s opinion, however, that all material adjustments (consisting of            normal recurring adjustments) have been made that are necessary for a fair financial            statements presentation. The results for the interim period are not necessarily            indicative of the results to be expected for the year. The interim consolidated            financial statements should be read in conjunction with the Company’s annual            report on Form 10-KSB for the year ended December 31, 2006, and the quarterly reports            on Form 10-QSB for the quarters ended March 31, 2007, and June 30, 2007, including the            financial statements and notes thereto.

 

**Note 2 – Organization and Summary of Significant Accounting            Policies**

 

***Nature of Business***– TetriDyn            Solutions, Inc. (the “Company”) and its wholly owned and controlled            subsidiaries specialize in providing technology and data integration solutions that            increase professional or worker productivity through the use of customized data input            screens, wireless technologies, and improved information technology (IT) processes. The            Company’s solutions are comprised of varying mixtures of proprietary software,            third-party products, and IT consulting services. These solutions are currently focused            in the healthcare industry, with new applications being developed for the livestock and            other industries.

 

***Principles of Consolidation –***The consolidated financial statements include the accounts of the            Company and its wholly owned subsidiary, an Idaho corporation also named TetriDyn            Solutions, Inc., and results of operations of its 39.8% owned variable interest entity,            Southfork Solutions, Inc. Intercompany accounts and transactions have been eliminated            in consolidation (see Note 6).

 

***Cash and Cash Equivalents –***For purposes of the cash flow statements, the Company considers all            highly liquid investments with original maturities of three months or less at the time            of purchase to be cash equivalents.

 

***Use of Estimates –***In            preparing financial statements in conformity with generally accepted accounting            principles, management is required to make estimates and assumptions that affect the            reported amounts of assets and liabilities and the disclosure of contingent assets and            liabilities at the date of the financial statements and revenues and expenses during            the reported period. Actual results could differ from these estimates.

 

***Revenue Recognition –***The            Company’s AeroMD EMR, or electronic medical records, software is provided as            turnkey software that has been customized for specific medical specializations. The            Company typically installs the software at the customer’s location for a fee and            charges the customer a monthly license fee, based on the number of operating            workstations, under a one- or two-year usage agreement. The customer is entitled to all            systems upgrades during the one- or two-year license. At the end of their contracts,            customers may continue using AeroMD by entering into a new license with the Company.            The Company also sells installation and post-contract telephone support service            contracts on an hourly basis. The Company does not provide any rights of return or            warranties on its AeroMD EMR software.

 

6

----

**TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY**

**Notes to the Condensed Consolidated Financial            Statements**

(Unaudited)

 

Revenue from software licenses and related installation and support            services is recognized when earned and realizable. Revenue is earned and realizable            when persuasive evidence of an arrangement exists, services, if requested by the            customers, have been rendered and are determinable, and collectibility is reasonably            assured. Amounts received from customers prior to these criteria being met are            deferred. Revenue from the sale of software is recognized when delivered to the            customer or upon installation of the software if an installation contract exists.            Revenue from post-contract telephone support service contracts is recognized as the            services are provided, determined on an hourly basis. Revenue applicable to            multiple-element fee arrangements is divided among the software, the installation, and            post-contract support service contracts using vendor-specific objective evidence of            fair value, as evidenced by the prices charged when the software and the services are            sold as separate products or arrangements.

 

The            Company also provides information technology management consulting services. To date,            these services have been primarily in the hospital industry. These services are paid            for on a monthly basis and for a flat-fee, which is not cancelable or refundable.            Revenue for these services is recognized over the contract period.

 

The            Company had one customer that represented 78% and 75% of sales for the three- and            nine-month periods ended September 30, 2007, respectively. This same customer            represented 77% of sales for both the three- and nine-month periods ended September 30,            2006. This customer is a regional hospital that contracted with the Company for IT            consulting and management services.

 

***Income Taxes –***The Company            utilizes the liability method of accounting for income taxes. Under the liability            method, deferred tax assets and liabilities are determined based on temporary            differences between financial reporting and tax bases of assets and liabilities and on            the amount of operating loss carry-forwards, and are measured using the enacted tax            rates and laws that will be in effect when the temporary differences and carry-forwards            are expected to reverse. An allowance against deferred tax assets is recorded when it            is more likely than not that such tax benefits will not be realized.

 

***Going Concern –***During the            three and nine months ended September 30, 2007, the Company suffered losses of $42,763            and $188,853, respectively. At September 30, 2007, the Company had a working capital            deficit of $485,012 and a capital deficit of $664,752. These matters raise doubt about            the Company’s ability to continue. In addition, management is trying to expand            the Company’s sales and obtain profitable operations. The accompanying condensed            consolidated financial statements do not include any adjustments relating to the            recoverability and classification of asset carrying amounts or the amount and            classification of liabilities that might result should the Company be unable to            continue as a going concern.

 

***Business Segments –***The            Company operates in one segment and therefore segment information is not            presented.

 

***Fair Value of Financial Instruments –***The carrying amounts of the Company’s accounts receivable,            restricted cash, accounts payable, notes payable to related parties, notes payable, and            deferred compensation approximate fair value due to the relatively short period to            maturity for these instruments.

 

7

 

----

**TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY**

**Notes to the Condensed Consolidated Financial            Statements**

(Unaudited)

 

***Property and Equipment –***Property and equipment are recorded at cost. Maintenance, repairs, and            renewals that neither materially add to the value of the property nor appreciably            prolong its life are charged to expense as incurred. Property and equipment are            depreciated using the straight-line method over the estimated useful lives of the            assets. Gains or losses on dispositions of property and equipment are included in the            results of operations when realized.

 

***Net Loss Per Common Share –***Basic and diluted net loss per common share is computed based upon the            weighted-average stock outstanding as defined by Financial Accounting Standards No.            128, “*Earnings Per            Share*.” As of September 30, 2007 and 2006, 1,633,000            and 0 (zero), respectively, of common share equivalents were antidilutive and not used            in the calculation of diluted net loss per share.

 

***Stock-Based Compensation –***On            May 15, 2006, at a special shareholders’ meeting, the Company’s            shareholders approved the 2006 Long-Term Incentive Plan under which up to 4,000,000            shares of common stock may be issued. The 2006 plan is to be administered either by the            board of directors or by the appropriate committee to be appointed from time to time by            such board of directors. Awards granted under the 2006 plan may be incentive stock            options (“ISOs”) (as defined in the Internal Revenue Code), appreciation            rights, options that do not qualify as ISOs, or stock bonus awards that are awarded to            employees, officers, and directors who, in the opinion of the board or the committee,            have contributed or are expected to contribute materially to the Company’s            success. In addition, at the discretion of the board of directors or the committee,            options or bonus stock may be granted to individuals who are not employees, officers,            or directors, but contribute to the Company’s success.

 

Effective January 1, 2006, the Company adopted the provisions of            Statement of Financial Accounting Standards, or SFAS, No. 123R,*Share-Based Payment*(“SFAS            123R”), for its stock-based compensation plan. Under SFAS 123R, all employee            stock-based compensation is measured at the grant date, based on the fair value of the            option or award, and is recognized as an expense over the requisite service, which is            typically through the date the options or awards vest. The Company adopted SFAS 123R            using the modified prospective method. Under this method, for all stock-based options            and awards granted prior to January 1, 2006, that remain outstanding as of that date,            compensation cost is recognized for the unvested portion over the remaining requisite            service period, using the grant-date fair value measured under the original provisions            of SFAS No. 123, “*Accounting for Stock-Based            Compensation,*” for pro forma and disclosure purposes.            Furthermore, compensation costs will also be recognized for any awards issued,            modified, repurchased, or cancelled after January 1, 2006.

 

As            the result of adoption of SFAS 123R, the Company recognized $9,414 and $32,905 of            compensation during three and nine months ended September 30, 2007, respectively,            relating to stock options granted in May 2007 and that were outstanding at September            30, 2007 (see Note 4).

 

***Recent Accounting Pronouncements –***In September 2006, the Financial Accounting Standards Board, or FASB,            issued SFAS No. 157, “*Fair Value            Measurements.*” The objective of SFAS 157 is to increase            consistency and comparability in fair value measurements and to expand disclosures            about fair value measurements. SFAS 157 defines fair value, establishes a framework for            measuring fair value in generally accepted accounting principles, and expands            disclosures about fair value measurements. SFAS 157 applies under other accounting            pronouncements that require or permit fair value measurements and does not require any            new fair value measurements. The provisions of SFAS 157 are effective for fair value            measurements made in fiscal years beginning after November 15, 2007. The adoption of            this statement is not expected to have a material effect on the Company’s future            reported financial position or results of operations.

 

8

 

----

**TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY**

**Notes to the Condensed Consolidated Financial            Statements**

(Unaudited)

 

In            February 2007, the FASB issued SFAS No. 159, “*The Fair            Value Option for Financial Assets and Financial Liabilities – Including an            Amendment of FASB Statement No. 115.*” This statement            permits entities to choose to measure many financial instruments and certain other            items at fair value. Most of the provisions of SFAS 159 apply only to entities that            elect the fair value option. However, the amendment to SFAS No. 115,            “*Accounting for Certain Investments in Debt and Equity            Securities,*” applies to all entities with            available-for-sale and trading securities. SFAS 159 is effective as of the beginning of            an entity’s first fiscal year that begins after November 15, 2007. Early adoption            is permitted as of the beginning of a fiscal year that begins on or before November 15,            2007, provided the entity also elects to apply the provision of SFAS            157*.*The adoption of this statement            is not expected to have a material effect on the Company’s financial            statements.

 

***Reclassifications –***Certain            amounts in the 2006 information have been reclassified to conform to the 2007            presentation. These reclassifications had no impact on the Company’s net loss or            cash flows.

 

**Note 3 – Restatement of Financial Statements**

 

The            financial statements for the nine months ended September 30, 2006, have been restated            due to the Company determining that the shares paid to a consultant for services            related to the 2006 reverse acquisition needed to be valued at the time of the reverse            acquisition rather than at the time of the agreement due to contingencies in the            agreement based upon completion of the reverse acquisition. This restatement caused the            professional fees expense for the nine months ended September 30, 2006, to be increased            by $360,000, resulting in the net loss for the same nine-month period being increased            by $360,000.

 

**Note 4 – Stockholders’ Equity**

 

In            January 2007, the Company entered into a consulting agreement with a consultant for            investor relations services. The agreement calls for the consultant to provide services            for a period of one year. The Company sold the consultant 450,000 shares of common            stock for cash proceeds of $450 and recorded the fair value of the common stock of            $315,000. The fair value of the common stock will be recognized as an expense over the            term of the agreement. For the three and nine months ended September 30, 2007, the            Company recognized consulting expense of $78,637 and $222,627 under the agreement,            respectively.

 

In            April 2007, the Company agreed to pay the amount owed to the stockholder discussed in            Note 5, including all accrued interest, with the Company’s common stock at the            fair value on the date of the conversion. The balance including accrued interest due to            the stockholder in April 2007 was $84,080. As a result, the Company issued 420,401            shares of common stock for the cancellation of the debt to the stockholder and no gain            or loss was recognized on the conversion.

 

In            May 2007, the Company granted 55,556 shares of common stock to each of its outside            directors (111,112 total shares) for their services valued at the fair value on the            date of grant of $10,000. The Company also granted 15,000 shares of common stock to an            employee as a bonus valued at the fair value on the date of grant of $1,350. Also in            May 2007, the Company granted 1,639,000 stock options to employees, executives, and            directors. Stock option compensation expensed in the nine months ended September 30,            2007 is the estimated fair value of options granted amortized on a straight-line basis            over the requisite service period for the entire portion of the award. In August 2007,            6,000 of the employee stock options were exercised for $540.

 

9

 

----

**TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY**

**Notes to the Condensed Consolidated Financial            Statements**

(Unaudited)

 

The            fair value of options at the date of grant is estimated using the Black-Scholes option            pricing model. The assumptions made in calculating the fair values of options are as            follows:

 

|                     |   | For the Nine Months Ended September 30, 2007 |
|--------------------------|--------|----------------------------------------------|
|                     |   | Employees                                    |   | Executives |   | Directors |   |
| Expected term (in years) |   | 2.5                                          |   | 1 |   | 0.08 to 0.75 |   |
| Expected volatility      |   | 79%                                          |   | 79% |   | 79% |   |
| Expected dividend yield  |   | 0%                                           |   | 0% |   | 0% |   |
| Risk-free interest rate  |   | 4.69%                                        |   | 4.87% |   | 4.72% to 4.91% |   |

 

A            summary of the status of the Company’s stock options as of September 30, 2007 and            the changes during the period ended is presented below:

 

| Weighted AverageFixed Options                                                                                   |   | Shares |      | Exercise Price |   |
|-----------------------------------------------------------------------------------------------------------------|--------|--------|-----------|----------------|--------|
| Outstanding at beginning of year                                                                                |   |   | --        |           | $      | -- |   |
| Issued                                                                                                          |   |   | 285,000   |           |   | 0.09 |   |
| Issued                                                                                                          |   |   | 1,360,000 |           |   | 0.10 |   |
| Exercised                                                                                                       |   |   | 6,000     |           |   | 0.09 |   |
| Cancelled                                                                                                       |   |   | 6,000     |           |   | 0.09 |   |
| Outstanding at September 30, 2007                                                                               |   |   | 1,633,000 |           |   |   |   |
| Exercisable at September 30, 2007                                                                               |   |   | 816,500   |           |   |   |   |
| Weighted average exercise price of options granted                            toemployees at September 30, 2007 |   | $      | 0.10      |           |   |   |   |

 

 

| Exercise Price |   | NumberOutstandingat September 30, 2007 |      | WeightedAverageRemainingContractual Life |   | WeightedAverageExercise Price |   | NumberExercisable atSeptember 30, 2007 |   | WeightedAverageExercise Price |   |
|----------------|--------|----------------------------------------|-----------|------------------------------------------|--------|-------------------------------|--------|----------------------------------------|--------|-------------------------------|--------|
| $0.09          |   |                                   | 273,000   |                                     |   | 7.5                           |   | $                                      | 0.09   |                          |   | 136,500 |   | $ | 0.09 |   |
| $0.10          |   |                                   | 1,360,000 |                                     |   | 4,7                           |   | $                                      | 0.10   |                          |   | 680,000 |   | $ | 0.10 |   |

 

**Note 5 – Related Party Transactions**

 

The            Company had amounts due to a stockholder for funds loaned to the Company and for            Company expenditures covered by the stockholder. The balances due to the stockholder at            September 30, 2007, and December 31, 2006, were $0 and $77,751, respectively. The notes            payable bore interest at 6% per annum. During May 2006, the stockholder and the Company            agreed to modify the terms of the notes payable such that they were due on May 30,            2008. During April 2007, the stockholder and the Company agreed to convert the note            payable and accrued interest into 420,401 shares of common stock at the fair value on            the date of conversion (see Note 4).

 

10

 

----

**TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY**

**Notes to the Condensed Consolidated Financial            Statements**

(Unaudited)

 

**Note 6 – Variable Interest Entities**

 

In            December 2003, the FASB issued a revision to Interpretation No. 46,*Consolidation of Variable Interest Entities*(“FIN No. 46R”), which was originally issued in January            2003. FIN No. 46R provides guidance on the consolidation of certain entities when            control exists through means other than ownership of voting (or similar) interests and            was effective for public entities that have interests in variable interest entities            commonly referred to as special purpose entities for the first reporting period that            ends after March 15, 2004. FIN No. 46R requires consolidation by the majority holder of            expected residual gains and losses of the activities of a variable interest entity            (“VIE”).

 

As            of September 30, 2007, the Company owned 39.8% of the voting interest in Southfork            Solutions, Inc., an Idaho corporation. Southfork Solutions’ objective is to            provide electronic livestock verification and tracking throughout the entire livestock            lifecycle. In July 2007, the Company entered into an agreement with Southfork            Solutions. The agreement details the stock compensation that Southfork Solutions will            pay to the Company for management services, as well as cash compensation that Southfork            Solutions will pay to the Company for technical services, including but not limited to            engineering, marketing, bookkeeping, and administration. According to the agreement,            Southfork Solutions will compensate the Company with 45,000 common shares per month for            management services and with cash based upon hours spent for all other            services.

 

The            Company has concluded that Southfork Solutions meets the definition of a VIE because            the Company has an agreement with Southfork Solutions to fully manage and control the            financial direction of Southfork Solutions and is the primary beneficiary of its            operations.

 

The            effect of the VIE’s consolidation on the Company’s consolidated balance            sheet at September 30, 2007, was an increase in the Company’s assets and            liabilities of $25,159 and $4,920, respectively. The Company also recognized            non-controlling interest income of $143,674 for the nine months ended September 30,            2007.

 

**Note 7 – Subsequent Event**

 

On            October 9, 2007, the Company’s 39.8% VIE, Southfork Solutions, Inc., received the            second installment of $90,000 of investment funds to total $500,000 from one of its            joint venture investors. The investment is to be utilized specifically to develop            livestock tracking trials using TetriDyn’s E-Trace program and newly-developed            Radio Frequency Identification (RFID) livestock ear tags.

 

11

 

----

**ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF            OPERATION**

 

The            following discussion should be read in conjunction with our unaudited condensed            consolidated financial statements and notes to our financial statements included            elsewhere in this report. This discussion contains forward-looking statements that            involve risks and uncertainties. Actual results could differ materially from those            anticipated in these forward-looking statements as a result of various factors            discussed elsewhere in this report.

 

Certain information included herein contains statements that may be            considered forward-looking statements within the meaning of Section 27A of the            Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act            of 1934, as amended, such as statements relating to our anticipated revenues, gross            margin and operating results, future performance and operations, plans for future            expansion, capital spending, sources of liquidity, and financing sources. Such            forward-looking information involves important risks and uncertainties that could            significantly affect anticipated results in the future, and accordingly, such results            may differ from those expressed in any forward-looking statements made herein. These            risks and uncertainties include those relating to our liquidity requirements, the            continued growth of the mobility software industry, the success of our            product-development, marketing and sales activities, vigorous competition in the            software industry, dependence on existing management, leverage and debt service            (including sensitivity to fluctuations in interest rates), domestic or global economic            conditions, the inherent uncertainty and costs of prolonged arbitration or litigation,            and changes in federal or state tax laws or the administration of such laws.

 

**Overview**

 

We            specialize in providing technology and data integration solutions that increase            professional or worker productivity through the use of customized data input screens,            wireless technologies, and improved information technology (IT) processes. Our            solutions are comprised of varying mixtures of proprietary software, third-party            products, and IT consulting services. These solutions are currently focused in the            healthcare industry, with new applications being developed for the food security and            other industries.

 

We            have targeted two major industries that we believe have significant needs that our            products help address: healthcare and food security. Our unique proprietary EMR            (electronic medical record) software will help hospitals and doctors’ offices            adapt to electronic record systems, cutting down the traditional paper record system.            In the food security arena, we believe our E-Trace (electronic tracing) program is the            only electronic animal-tracking identification solution ready to meet significant needs            of the livestock industry.

 

**Description of Expenses**

 

General and administrative expenses consist primarily of salaries and            related costs for accounting, administration, finance, human resources, and information            systems.

 

Professional fees expenses consist primarily of fees related to legal,            outside accounting, auditing, and investor relations services.

 

Selling and marketing expenses consist primarily of advertising,            promotional activities, trade shows, travel, and personnel-related expenses.

 

Research and development expenses consist of payroll and related costs            for software engineers, management personnel, and the costs of materials used by these            employees in the development of new or enhanced product offerings.

 

12

 

----

In            accordance with Financial Accounting Standards Board, or FASB, Statement of Financial            Accounting Standards (“SFAS”) No. 86,            “*Accounting for the Costs of Computer Software to be            Sold, Leased or Otherwise Marketed,”*development costs            incurred in the research and development of new software products to be sold, leased,            or otherwise marketed are expensed as incurred until technological feasibility in the            form of a working model has been established. Internally generated, capitalizable            software development costs have not been material to date. We have charged our software            development cost to research and development expense in our statements of            operations.

 

Property and equipment are recorded at cost. Maintenance, repairs, and            renewals that neither materially add to the value of the property nor appreciably            prolong its life are charged to expense as incurred. Property and equipment are            depreciated using the straight-line method over the estimated useful lives of the            assets. Gains or losses on dispositions of property and equipment are included in the            results of operations when realized.

 

**Results of Operations**

 

**Comparison of Three and Nine Months Ended September 30, 2007 and            2006**

             

***Revenues***

             

Our            revenue was $287,193 and $846,241 for the three and nine months ended September 30,            2007, respectively, compared to $269,503 and $541,324 for the three and nine months            ended September 30, 2006, respectively, representing an increase of $17,690, or 7%, and            $304,917, or 56%, for the three- and nine-month periods, respectively. The increase in            revenues was due to an expansion in our existing consulting services to a regional            hospital in August 2007, the addition of another consulting agreement with a regional            surgery center in March 2007, and increased AeroMD and third-party software sales            throughout the nine months ended September 30, 2007.

 

***Cost of Revenue***

             

Our            cost of revenue was $108,637 and $302,495 for the three and nine months ended September            30, 2007, respectively, compared to $88,011 and $195,020 for the three and nine months            ended September 30, 2006, respectively, representing an increase of $20,626, or 23%,            and $107,475, or 55%, for the three- and nine-month periods, respectively. The gross            margin percentage on revenue was 62% and 64% for the three and nine months ended            September 30, 2007, respectively, and 67% and 64% for the three and nine months ended            September 30, 2006, respectively. The decrease in the gross margin percentage for the            three months ended September 30, 2007, from the three months ended September 30, 2006,            was primarily due to increased support costs on the consulting contracts.

 

Although the net changes and percent changes with respect to our            revenues and our cost of revenue for the three and nine months ended September 30, 2007            and 2006, are summarized above, the trends contained therein are limited and should not            be viewed as a definitive indication of our future results.

 

***Operating Expenses***

             

General and Administrative — General and administrative expenses,            including noncash compensation expense, were $53,877 and $180,624 for the three and            nine months ended September 30, 2007, respectively, compared to $46,689 and $148,948            for the three and nine months ended September 30, 2006, respectively, representing an            increase of $7,188, or 15%, and $31,676, or 21%, for the three- and nine-month periods,            respectively. The increase in our general and administrative expenses from the three-            and nine-month periods ended September 30, 2007, as compared to the three and nine            months ended September 30, 2006, reflects an increase in payroll costs in 2007 due to            an additional administrative staff member and an increase in salaries to existing            personnel compared to the same periods in 2006.

 

13

 

----

Professional Fees — Professional fees expenses, including noncash            compensation expense, were $113,512 and $298,997 for the three and nine months ended            September 30, 2007, respectively, compared to $83,871 and $562,476 for the three and            nine months ended September 30, 2006, representing an increase of $29,641, or 35%, for            the three-month period and a decrease of $263,479, or 47%, for the nine-month period.            The increase in our professional fees expenses from the three-month period ended            September 30, 2007, as compared to the three months ended September 30, 2006, was            primarily due to additional expenditures for corporate and legal fees associated with            Southfork Solutions. The decrease in our professional fees expenses from the nine-month            period ended September 30, 2007, as compared to the nine months ended September 30,            2006, reflects legal, auditing, and other consulting fees incurred in the first quarter            of 2006 directly related to the reverse acquisition of TetriDyn Solutions, Inc. by            Creative Vending Corp., the name and domicile change to Nevada, and Securities and            Exchange Commission filing requirements.

 

Selling and Marketing — Selling and marketing expenses, including            noncash compensation expense, were $76,363 and $199,230 for the three and nine months            ended September 30, 2007, respectively, compared to $77,265 and $198,301 for the three            and nine months ended September 30, 2006, respectively, representing a decrease of            $902, or 1% for the three-month period and an increase of $929, or less than 1%, for            the nine-month period. The changes in our selling and marketing expenses for the three-            and nine-month periods were immaterial.

 

Research and Development Expenses — Research and development            expenses were $109,270 and $155,214 for the three and nine months ended September 30,            2007, respectively, compared to $31,182 and $120,660 for the three and nine months            ended September 30, 2006, respectively, representing an increase of $78,088, or 250%,            and $34,554, or 29%, for the three- and nine-month periods, respectively. The increase            in research and development expenses reflects increased research and development            activities within and in support of Southfork Solutions, which we expect to continue            and possibly increase in coming months. The increased research and development            activities required the addition of two engineers to our staff.

 

Interest expense was $12,047 and $42,277 for the three and nine months            ended September 30, 2007, respectively, as compared to $15,493 and $57,450 for the            three and nine months ended September 30, 2006, respectively, representing a decrease            of $3,446, or 22%, and $15,173, or 26%, for the three- and nine-month periods,            respectively. The decrease in interest expense related primarily to our reduction of            debt on which interest was applied.

 

**Critical Accounting Policies**

 

We            have identified the policies outlined below as critical to our business operations and            an understanding of our results of operations. The list is not intended to be a            comprehensive list of all of our accounting policies. In many cases, the accounting            treatment of a particular transaction is specifically dictated by accounting principles            generally accepted in the United States, with no need for management’s judgment            in their application. The impact and any associated risks related to these policies on            our business operations is discussed throughout Management’s Discussion and            Analysis or Plan of Operations where such policies affect our reported and expected            financial results. For a detailed discussion on the application of these and other            accounting policies, see the Notes to the December 31, 2006 Consolidated Financial            Statements. Note that our preparation of the financial statements requires us to make            estimates and assumptions that affect the reported amount of assets and liabilities,            disclosure of contingent assets and liabilities at the date of our financial            statements, and the reported amounts of revenue and expenses during the reporting            period. There can be no assurance that actual results will not differ from those            estimates.

 

14

 

----

**Revenue Recognition**

             

Our AeroMD EMR software is provided as turnkey software that has been            customized for specific medical specializations. We typically install the software at            the customer’s location for a fee and charge the customer a monthly license fee,            based on the number of operating workstations, under a one- or two-year usage            agreement. The customer is entitled to all systems upgrades during the one- or two-year            license. At the end of their contracts, customers may continue using AeroMD by entering            into a new license with us. We also sell installation and post-contract telephone            support service contracts on an hourly basis. We do not provide any rights of return or            warranties on our AeroMD EMR software.

             

Revenue from software licenses and related installation and support            services is recognized when earned and realizable, which is when persuasive evidence of            an arrangement exists, services, if requested by the customers, have been rendered and            are determinable, and collectibility is reasonably assured. Amounts billed to customers            prior to these criteria being met are deferred. Revenue from the sale of software is            recognized when delivered to the customer or upon installation of the software if an            installation contract exists. Revenue from post-contract telephone support service            contracts is recognized as the services are provided, determined on an hourly basis.            Revenue applicable to multiple-element fee arrangements is divided among the software,            the installation, and post-contract support service contracts using vendor-specific            objective evidence of fair value. Fair value is evidenced by the prices charged when            the software and the services are sold as separate products or arrangements.

             

We also provide information technology management consulting services.            To date, these services have been primarily in the hospital industry. These services            are paid for on a monthly basis and for a flat-fee, which is not cancelable or            refundable. Revenue for these services is recognized over the contract            period.

 

**Income Taxes**

             

We utilize the liability method of accounting for income taxes. Under            the liability method, deferred tax assets and liabilities are determined based on            temporary differences between financial reporting and tax bases of assets and            liabilities and on the amount of operating loss carry-forwards, and are measured using            the enacted tax rates and laws that will be in effect when the temporary differences            and carry-forwards are expected to reverse. An allowance against deferred tax assets is            recorded when it is more likely than not that such tax benefits will not be            realized.

             

**Stock Based Compensation**

 

Effective January 1, 2006, the Company adopted the provisions of SFAS            No. 123 (revised), “*Share-Based            Payment*,” which replaces SFAS No. 123,            “*Accounting for Stock-Based            Compensation*,” and supersedes APB Opinion No. 25,            “*Accounting for Stock Issued to            Employees*,” and related interpretations. SFAS 123R            requires compensation costs related to share-based payment transactions, including            employee stock options, to be recognized in the financial statements. In addition, we            adhere to the guidance set forth within SEC Staff Accounting Bulletin No. 107, which            provides the views of the staff of the SEC regarding the interaction between SFAS 123R            and certain SEC rules and regulations and provides interpretations with respect to the            valuation of share-based payments for public companies.

             

15

 

----

In adopting SFAS 123R, we applied the modified prospective approach to            transition. Under the modified prospective approach, the provisions of SFAS 123R are to            be applied to new awards and to awards modified, repurchased, or cancelled after the            required effective date. Additionally, compensation cost for the portion of awards for            which the requisite service has not been rendered that are outstanding as of the            required effective date shall be recognized as the requisite service is rendered on or            after the required effective date. The compensation costs for that portion of awards            shall be based on the grant-date fair value of those awards as calculated for either            recognition or pro forma disclosures under SFAS 123.

 

**Recent Accounting Pronouncements**

 

In            September 2006, the FASB issued SFAS No. 157, “*Fair            Value Measurements.*” The objective of SFAS 157 is to            increase consistency and comparability in fair value measurements and to expand            disclosures about fair value measurements. SFAS 157 defines fair value, establishes a            framework for measuring fair value in generally accepted accounting principles, and            expands disclosures about fair value measurements. SFAS 157 applies under other            accounting pronouncements that require or permit fair value measurements and does not            require any new fair value measurements. The provisions of SFAS 157 are effective for            fair value measurements made in fiscal years beginning after November 15, 2007. The            adoption of this statement is not expected to have a material effect on our future            reported financial position or results of operations.

 

In            February 2007, the FASB issued SFAS No. 159, “*The Fair            Value Option for Financial Assets and Financial Liabilities – Including an            Amendment of FASB Statement No. 115.*” This statement            permits entities to choose to measure many financial instruments and certain other            items at fair value. Most of the provisions of SFAS 159 apply only to entities that            elect the fair value option. However, the amendment to SFAS No. 115,            “*Accounting for Certain Investments in Debt and Equity            Securities,*” applies to all entities with            available-for-sale and trading securities. SFAS is effective as of the beginning of an            entity’s first fiscal year that begins after November 15, 2007. Early adoption is            permitted as of the beginning of a fiscal year that begins on or before November 15,            2007, provided the entity also elects to apply the provision of SFAS 157. The adoption            of this statement is not expected to have a material effect on our financial            statements.

 

**Liquidity and Capital Resources**

 

At            September 30, 2007, our principal source of liquidity consisted of $85,065 of cash, as            compared to $81,723 of cash at December 31, 2006. In addition, our stockholders’            deficit was $664,752 at September 30, 2007, compared to stockholders’ deficit of            $827,851 at December 31, 2006, a decrease in the deficit of $163,099.

 

Our            operations provided net cash of $59,816 during the nine months ended September 30,            2007, as compared to using $134,451 of net cash during the nine months ended September            30, 2006. The $194,267 decrease in the net cash used by our operating activities            primarily resulted from the reduced loss in the nine months ended September 30, 2007,            compared to the nine months ended September 30, 2006.

 

During the three and nine months ended September 30, 2007, we suffered            losses of $42,763 and $188,853, respectively. However, $88,151 and $266,882 of the            expenses for the three and nine months ended September 30, 2007, respectively, were            attributable to stock-based compensation either issued or granted in the form of stock            options to consultants and employees; without these noncash stock expenses, we would            have realized a net income.

 

16

 

----

Investing activities for the nine months ended September 30, 2007, used            $9,045 of net cash, as compared to $6,588 of net cash used during the nine months ended            September 30, 2006. The increase in net cash used related to increased property or            equipment purchases in the nine months ended September 30, 2007.

 

Financing activities used $47,429 during the nine months ended September            30, 2007, compared to providing net cash of $104,127 during the nine months ended            September 30, 2006. The decrease of $151,556 of net cash provided in financing            activities was primarily due to the sale of stock in 2006 and the increase in notes            payable repayments in 2007.

 

We            are focusing our efforts on increasing revenue while we explore external funding            alternatives. In addition, we intend to seek compromise and resolution of $125,000 in            indebtedness due a community development agency, now in default, principally by            execution on the collateral. We currently have contracts in place for IT services and            future deliveries of our AeroMD product that we believe will cover our minimum            expenditures for operating costs and minimum installments due on our other indebtedness            to non-affiliates during the next 12 months. We expect that additional sales will            enable us to increase our payments on indebtedness and support the development of other            products.

 

In            order for us to expand our AeroMD market penetration and to pursue the development of            our E-Trace program leading to product roll-out, we will be required to increase our            revenues substantially and to seek additional external capital. Our growth within            E-Trace will be severely restricted if we are unable to obtain external funding.            E-Trace is currently being funded by an investor within the cattle industry through            Southfork Solutions. The growth of the E-Trace program is dependent upon the further            investment by the current investor or additional funding being raised. Proceeds from            investments into Southfork Solutions benefit us since Southfork Solutions pays us cash            for research and development services we provide to Southfork Solutions.

 

On            October 25, 2006, our common stock began being quoted on the OTCBB and the Pink Sheets,            which we anticipate may improve our access to equity capital. Additionally, as we            continue development of new products and identify specific commercialization            opportunities, we will focus on those product markets and opportunities for which we            might be able to get external funding through joint venture agreements, strategic            partnerships, or other direct investments.

 

We            have no significant contractual obligations or commercial commitments not reflected on            our balance sheet as of this date.

 

**ITEM 3. CONTROLS AND PROCEDURES**

 

We            maintain disclosure controls and procedures that are designed to ensure that            information required to be disclosed by us in the reports that we file or submit to the            Securities and Exchange Commission under the Securities Exchange Act of 1934, as            amended, is recorded, processed, summarized, and reported within the time periods            specified by the Securities and Exchange Commission’s rules and forms, and that            information is accumulated and communicated to our management, including our principal            executive and principal financial officers (whom we refer to in this periodic report as            our Certifying Officers), as appropriate to allow timely decisions regarding required            disclosure. Our management evaluated, with the participation of our Certifying            Officers, the effectiveness of our disclosure controls and procedures (as defined in            Rule 13a-15(e) under the Securities Exchange Act) as of September 30, 2007, pursuant to            Rule 13a-15(b) under the Securities Exchange Act. Based upon that evaluation, our            Certifying Officers concluded that, as of September 30, 2007, our disclosure controls            and procedures were effective.

 

There were no changes in our internal control over financial reporting            that occurred during our most recently completed fiscal quarter that have materially            affected, or are reasonably likely to materially affect, our internal control over            financial reporting.

 

17

 

----

**PART II – OTHER INFORMATION**

 

**ITEM 6. EXHIBITS**

 

The            following exhibits are filed as a part of this report:

 

| **Exhibit Number*** |   |  

**Title of Document**                                                                                                                                                                                                      |   |  

**Location** |
|---------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------------|
|                |   |                                                                                                                                                                                                                               |   |                 |
| **Item 31**         |   | **Rule 13a-14(a)/15d-14(a)                            Certifications**                                                                                                                                                             |   |                 |
| 31.01               |   | Certification of Principal Executive Officer and                            Principal Financial Officer Pursuant to Rule 13a-14                                                                                                    |   | Attached             |
|                |   |                                                                                                                                                                                                                               |   |                 |
| **Item 32**         |   | **Section 1350 Certifications**                                                                                                                                                                                                    |   |                 |
| 32.01               |   | Certification Pursuant to 18 U.S.C. Section 1350, as                            Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                            (Chief Executive Officer and Chief Financial Officer) |   | Attached             |

_______________

| * | All exhibits are numbered with the number preceding the                            decimal indicating the applicable SEC reference number in Item 601 and                            the number following the decimal indicating the sequence of the                            particular document. |
|---|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

**SIGNATURE**

 

In            accordance with the requirements of the Exchange Act, the registrant caused this report            to be signed on its behalf by the undersigned, thereunto duly authorized.

 

|   | TETRIDYN SOLUTIONS, INC. |
|--------|--------------------------|

|   | (Registrant) |
|--------|--------------|

 

| Date: November 12, 2007 | By /s/ David W. Hempstead |
|-------------------------|---------------------------|

David W. Hempstead, President, Chief Executive Officer, and Chief            Financial Officer

 

18